Clinical Research Program
Participate in groundbreaking research to advance neural optimization technology and help shape the future of human performance.
Current Studies
Our clinical trials evaluate the safety and efficacy of the Areté Grain neural implant for human optimization applications.
PRIME Study - Focus & Productivity Enhancement
Study ID: WP-PRIME-001 | Phase: Early Feasibility
A first-in-human study evaluating the safety and preliminary efficacy of the Areté Grain system for real-time impulse control and sustained attention enhancement in healthy high-performing adults.
Duration
12 months
Participants
10 adults
Location
San Francisco, CA
RESTORE Study - Sleep Optimization
Study ID: WP-RESTORE-001 | Phase: Early Feasibility
Evaluating the Areté Grain system for on-demand sleep induction and improved sleep quality in adults with mild-to-moderate insomnia or irregular sleep patterns.
Duration
12 months
Participants
15 adults
Location
San Francisco, CA
Eligibility Criteria
General eligibility requirements for participation in Willpower clinical trials. Specific criteria may vary by study.
Age Requirement
Adults aged 22-55 years old in good general health
Neurological Health
No history of seizures, stroke, or significant neurological conditions
Commitment
Able to attend all scheduled study visits and follow-up assessments
MRI Compatible
No metal implants or conditions that preclude MRI imaging
What to Expect
Screening
Complete medical history, physical exam, neurological assessment, and MRI scan
Implantation
Minimally invasive "Needle-Drop" procedure performed by experienced neurosurgeon
Follow-up
Regular assessments over 12 months to monitor safety, device function, and outcomes
Patient Registry
Join the Willpower Patient Registry to stay informed about clinical trial opportunities and be among the first to know about new studies that match your profile.
About the Patient Registry
The Willpower Patient Registry is a secure database of individuals interested in participating in clinical trials for the Areté neural optimization platform. Registration is voluntary and does not obligate you to participate in any study.
By joining the registry, you will:
- •Receive notifications about clinical trials that match your profile
- •Get early access to new research opportunities
- •Stay informed about advances in neural optimization technology
- •Help advance medical research and innovation
Your privacy is protected. All registry information is kept confidential and secure in accordance with HIPAA regulations and our Privacy Policy. You may withdraw from the registry at any time.
Important Information
Investigational Device
The Areté Grain neural implant is an investigational device that has not been approved by the FDA for commercial use. It is only available through approved clinical trials under an Investigational Device Exemption (IDE).
Informed Consent
All participants must complete a thorough informed consent process before enrolling in any clinical trial. This includes detailed information about the study procedures, potential risks and benefits, and your rights as a research participant.
Privacy & Confidentiality
All clinical trial data is protected under HIPAA regulations. Your personal health information will only be shared with authorized study personnel and regulatory authorities as required by law. For more information, see our Privacy Policy.
Questions?
For more information about clinical trials or the patient registry, please contact our Clinical Research team at info@willpower.com.